Global healthcare by the numbers
The growing burden of noncommunicable diseases is no longer a problem associated with high-income countries. According to the World Health Organization, each year 17 million people die from an NCD before the age of 70, and 86% of those premature deaths occur in LMICs. The table below demonstrates results measured by the GHU over the past two years.
ACCESS TO MEDICINE
Focuses on improving access which led to the creation and launch of Impact®, a dedicated brand of affordable, quality Sanofi medications for patients with NCDs.
- >40LMIC countries supplied with NCD treatment
- 10countries supplied with Impact®
- 586,024 Patients reached with NCD treatment
- Target is 2M NCD Patients treated by 2030
HEALTH SYSTEMS STRENGTHENING
Involves strengthening fragile health systems through both financial and non-financial partner support ranging from supply chain, regulatory, healthcare delivery and HCP capacity building.
- 74 NCD Programs activated with 52 partners
- 39 countries covered
- 128 Health facilities engaged to optimize access and availability to NCD treatments
- 763,817 Beneficiaries reached with NCD Programs
- 12,453 HCPs and CHWs received NCD training
IMPACT INVESTING
The Impact Fund supports the scale‑up of inclusive sustainable ventures that enhance access to affordable quality treatments and care for underserved patients at the last mile, combining digital innovation and on-the-ground delivery models.
8.3M€ of investments in 5 organizations over 15 countries
- + 3,000 of Health Facilities served
- + 4,500,000 Patients indirectly reached through facilities
- + 2,000 HCPs received training